Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033

13 Jun 2025

Share :

Table of Content

1. Women's Health Therapeutics Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Women’s Health Therapeutics Market? 3. Segment Outlooks 4. Regional Insights 5. Women's Health Therapeutics Market Coverage 6. Women's Health Therapeutics Market Key Players

Women's Health Therapeutics Market Revenue and Trends 2025 to 2033

The global women's health therapeutics market revenue surpass USD 46.69 billion in 2025 and is predicted to attain around USD 64.04 billion by 2033, growing at a CAGR of 4.03%. The rising prevalence of women’s health conditions is expected to boost the growth of the market during the forecast period.

What are the Major Factors Driving the Growth of the Women’s Health Therapeutics Market?

The women's health therapeutics market is growing at a rapid pace, driven by several factors such as increased awareness of women's specific health conditions, such as endometriosis, polycystic ovary syndrome (PCOS), osteoporosis, and menopause-related disorders. Increased awareness leads to early diagnosis and higher demand for appropriate treatments. Technological advancements in drug therapy, including hormone therapy and biologics, expand treatment options and improve patient outcomes.

The growth of the aging female population, particularly in developed countries, significantly influences the rising need for treating chronic, hormonal health conditions, driving the growth of the market. Rising healthcare investments and government initiatives to improve women's access to high-quality healthcare also contribute to this growth.

Segment Outlooks

• By application, the contraceptives segment held the largest revenue share of the market in 2024. The increased awareness of reproductive health and family planning bolstered the demand for effective treatments, including contraceptives.
• By age, the 50 years and above segment contributed the largest market share in 2024 due to the high prevalence of both menopausal and postmenopausal conditions among aging female population.
• By drug, the Prolia segment dominated the market by holding the largest share in 2024. This medicine plays an essential role in preventing and treating osteoporosis in postmenopausal women.
• By distributional channel, the hospital pharmacies segment accounted for a significant share of the market in 2024 due to the easy availability of prescription drugs in these pharmacies. The rising hospital admission and patient pool support segmental growth.

Regional Insights

North America captured the biggest revenue share of the market in 2024. This is mainly due the well-established healthcare system in the U.S. and high healthcare spending. There is high awareness about women's health conditions, along with growing aging female population. This creates the need for effective therapeutics.

Asia Pacific is expected to expand rapidly in the market due to improvements in healthcare facilities and high focus on women’s health conditions. Government’s efforts to spread awareness about reproductive health further support regional market growth.

Women's Health Therapeutics Market Coverage

Recent Developments

• In February 2025, Adalvo, in collaboration with Wyntra achieved a significant milestone with the first launch from Adalvo’s Women's Health portfolio in the UK, reinforcing their shared commitment to expanding access to high-quality treatments. This launch addresses endometriosis that affects millions of women worldwide.
  (Source: https://biopharmaapac.com)

Women's Health Therapeutics Market Key Players

• Bayer AG
• Pfizer, Inc.
• Cipla Inc.
• Orchid Pharma.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical
• F. Hoffmann-La Roche Ltd.
• AbbVie
• Axena Health

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6220

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344